MedTech Acquisition Corp [Rocket]

Overview

MedTech Acquisition Corp

Add to portfolio

Recent News + Filings (All items)

Date Filed	Type	Description
10/03/2023	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
08/23/2023	SC 13G	Lombard International Assurance S.A. reports a 5.2% stake in TriSalus Life Sciences Inc.
08/22/2023	SC 13G	Stansky Michael P reports a 5.3% stake in TRISALUS LIFE SCIENCES, INC.
08/21/2023	SC 13D	MATLIN DAVID J reports a 8.2% stake in TriSalus Life Sciences, Inc.
08/21/2023	SC 13G	Dewey Christopher C reports a 5.6% stake in TRISALUS LIFE SCIENCES, INC.
08/21/2023	SC 13D	Wahlstrom Mats reports a 10.4% stake in TriSalus Life Sciences, Inc.
08/21/2023	SC 13G	MCGREVIN GENE R reports a 5.3% stake in TriSalus Life Sciences, Inc.

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-22	Dec-31-21
Revenues	0.0	0.0
Cost of goods sold	0.0	0.0
Gross profit	0.0	0.0
General and administrative	2.7	3.0
EBIT	-2.7	-3.0
Pre-tax income	6.1	4.8
Income taxes	0.6	0.0
Tax rate	9.3%	0.0%
Net income	5.5	4.8

Diluted EPS	$0.19	$0.15
Shares outstanding (diluted)	29.6	31.3

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy